SCHEMBL3515943

SCHEMBL3515943

CCC(C[N+]1(NC(=O)c2ccccc2OC)CCCCC1)OC(=O)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.44
▸ RAB9A P51151 4/20 0.44
▸ KCNA3 P22001 1/20 0.43
▸ CTSD P07339 1/20 0.41
▸ ALDH1A1 P00352 5/20 0.41
▸ MAPT P10636 3/20 0.40
▸ HPGD P15428 2/20 0.40
▸ TP53 P04637 2/20 0.40
▸ GLA P06280 1/20 0.40
▸ MAPK1 P28482 2/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ KCNK3 O14649 1/20 0.39
▸ KCNK9 Q9NPC2 1/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3620517 0.93 CTSD (0.43) NPC1RAB9ACTSDALDH1A1MAPT
SCHEMBL3521802 0.89 KMT2A (0.41) NPC1RAB9ACTSDALDH1A1MAPT
SCHEMBL3521719 0.89 CTSD (0.43) NPC1RAB9AKCNA3CTSDALDH1A1
SCHEMBL3516277 0.86 KMT2A (0.46) NPC1RAB9AKCNA3ALDH1A1MAPT
SCHEMBL3521477 0.86 CTSD (0.41) NPC1RAB9ACTSDALDH1A1MAPT
SCHEMBL3516887 0.82 CTSD (0.47) NPC1RAB9ACTSDALDH1A1MAPT
SCHEMBL13115478 0.80 NPC1 (0.39) NPC1RAB9AKCNA3ALDH1A1MAPT
SCHEMBL13115474 0.72 ATM (0.36) NPC1RAB9ACTSDALDH1A1MAPT
SCHEMBL15031355 0.72 CTSD (0.45) NPC1RAB9AKCNA3CTSDALDH1A1
SCHEMBL15031356 0.69 ALDH1A1 (0.45) NPC1RAB9AKCNA3CTSDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8466238-B2 Latent curing agents, epoxy resin compositions containing the same, sealing materials, and organic EL displays MITSUI CHEMICALS, INC. (JP) 2013-06-18 — — US disclosed
US-20100253213-A1 LATENT CURING AGENTS, EPOXY RESIN COMPOSITIONS CONTAINING THE SAME, SEALING MATERIALS, AND ORGANIC EL DISPLAYS MITSUI CHEMICALS, INC (JP) 2010-10-07 — — US disclosed
US-20100253213-A1 LATENT CURING AGENTS, EPOXY RESIN COMPOSITIONS CONTAINING THE SAME, SEALING MATERIALS, AND ORGANIC EL DISPLAYS MITSUI CHEMICALS, INC (JP) 2010-10-07 — — US disclosed
EP-2199313-A1 LATENT CURING AGENTS, EPOXY RESIN COMPOSITIONS CONATING THE SAME, SEALING MATERIALS, AND ORGANIC EL DISPLAYS Mitsui Chemicals, Inc. (JP) 2010-06-23 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100253213-A1 LATENT CURING AGENTS, EPOXY RESIN COMPOSITIONS CONTAINING THE SAME, SEALING MATERIALS, AND ORGANIC EL DISPLAYS LTA4H, EPHX2, EPHX1 NPC1 1783/4885RAB9A 3425/4885KCNA3 1346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback